HTA Accelerator

HTA Accelerator to support strategic payer decisions and market access

The Health Technology Assessment (HTA) Accelerator from IQVIA lets you analyze past and current payer assessments and evidence requirements to guide clinical trial design and market access strategy across the product lifecycle.
Screenshot on laptop

See your product the way payers do

Accelerate your knowledge of trends, decision-drivers and emerging themes in payer assessments with IQVIA's HTA Accelerator. With HTA Accelerator, you can have direct insight into payer decisions and requirements and advanced analytic capabilities to guide market access strategy from research to launch to market expansion.

The HTA Accelerator shows you payer requirements by market, disease or product category. It delivers a nuanced understanding of the dynamic payer environment based on HTA reports of more than 100 agencies in 41 countries. With new drugs coming to market every month, it also provides near real-time data on recent product submissions that could affect your future plans.

Strengthen your case at every stage

Through the HTA Accelerator you have direct access to payer insights to

  • Identify payer evidentiary needs and requirements
  • Guide clinical trial design that include payer relevant endpoints
  • Identify emerging trends and hurdles in payer assessments
  • Define an RWE strategy that payers are more likely to accept
  • Evaluate of the payer landscape for product in-licensing
  • Learn from recent decisions in the same therapy area or in analogous situations
  • Gain near-time access to information that enables faster and smarter decision- making

Now you can shape trial design using the type of data that is aligned with payer requirements in your market. You can review regulatory approval to identify market access restrictions. For products in market, you can monitor payer assessments that could impact future reimbursement and pricing for your product.

The information in HTA Accelerator is organized in eleven data sources starting with clinical trials followed by regulatory approvals, HTA outcomes, pricing, reimbursement, treatment costs, innovative agreements as well as country, agency and policy updates.

Analysis across the product lifecycle

HTA Accelerator

Work with IQVIA experts and platforms

You can use HTA Accelerator as a standalone software platform to give your team simple access to payer information. You can work with IQVIA experts to identify trends, design research or perform in-depth patient and market reviews.

HTA Accelerator services can include

  • Advanced / predictive analytics with IQVIA X
  • Evidence assessment
  • Landscape review
  • Quarterly or monthly trackers
  • Newsletter
  • Ad-hoc requests
  • Natural language processing

HTA Accelerator is part of IQVIA's Pricing and Market Access solutions, which integrate pricing, launch planning and other IQVIA offerings into a customized approach based on your product development needs.

Related solutions

Contact Us